Baumer

Baumer Rule of 40

The Rule of 40 of Baumer (BALM4.SA) as of Nov 15, 2026 is 32.67 %. In the previous year, Rule of 40 was 16.26 % — a change of 100.99% (higher).

Rule of 40

32.67 %

YoY

100.99%

Last updated:

Rule of 40 of Baumer is 2024 32.67 % . Rule of 40 of Baumer was 2023 16.26 % . It decreases by 100.99% higher compared to the previous year.

The Baumer Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2017
0.06 BRL
Jan 1, 2018
13.66 BRL
Jan 1, 2019
30.77 BRL
Jan 1, 2020
19.62 BRL
Jan 1, 2021
-8.75 BRL
Jan 1, 2022
33.83 BRL
Jan 1, 2023
16.26 BRL
Jan 1, 2024
32.67 BRL
The Baumer Rule of 40 history
YEARRule of 40YoY
32.67 %+100.99%
16.26 %-51.94%
33.83 %-486.80%
-8.75 %-144.58%
19.62 %-36.25%
30.77 %+125.26%
13.66 %+21,522.72%
0.06 %-99.31%
9.14 %+0.30%
9.11 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Baumer Stock analysis

What does Baumer do? Baumer SA generates revenue through the sale of medical equipment and solutions across its four business units. The Orthopedic unit produces and sells orthopedic implants and instruments, while the Hospital unit manufactures equipment for hospitals and industries including pharmaceutical, chemical, cosmetic, and food sectors. The Genius unit focuses on biomaterials, and the Brown unit supplies laundry equipment for hospitals, industrial, and hotel settings. The company's subsidiaries, Hospitalar Sul Ltda and Waldsea Investment SA, support its operations as of December 31, 2011. The primary buyers of Baumer SA's products include hospitals, pharmaceutical companies, chemical manufacturers, cosmetic firms, and food industry businesses. Additionally, industrial and hotel sectors purchase the laundry equipment from the Brown unit. The company's technical assistance services for medical apparatus also contribute to its revenue stream. Baumer SA's business model relies on direct sales of its specialized equipment and solutions to healthcare and industrial clients. The firm's product portfolio spans orthopedic care, hospital infrastructure, biomaterials, and laundry systems, catering to both medical and non-medical industrial applications. This diversified approach allows the company to serve multiple segments within the health and industrial markets. Baumer is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Baumer stock

Rule of 40 of Baumer is 32.67 % in 2024.

On Eulerpool you can find the complete historical development of Rule of 40 Baumer since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Baumer

All Key Metrics — Baumer